对FDA批准的向治疗和免疫治疗对急性淋巴细胞白血病 (ALL) 的反应的预测
Zakaria Yahya Khawaji1, Nussaiba Yahya Khawaji2, Mohammed Abdullah Alahmadi3
1College of Medicine, Taibah University, Madinah, Kingdom of Saudi Arabia. Zakaria.khawaji1@gmail.com.
Current treatment options in oncology
|August 5, 2024
概括
准确的风险分层和最小残留疾病 (MRD) 评估对于预测急性淋巴细胞白血病 (ALL) 的结果至关重要. 新型疗法正在改善缓解和生存率,指导精准医学方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 急性淋巴细胞白血病 (ALL) 是一种主要的儿科癌症,在成年人中很少见.
- 风险分层预治疗对于预后至关重要.
- 传统化疗改善了治疗结果,但也带来了耐药性和毒性等挑战.
研究的目的:
- 突出治疗前风险因素和最小残留疾病 (MRD) 在ALL管理中的重要性.
- 审查复发性/耐药性ALL新疗法的进展.
- 强调需要精准医学来定制ALL治疗的必要性.
主要方法:
- 对治疗前评估因素的审查,包括年龄,白细胞计数,免疫类型和细胞遗传学.
- 通过流细胞计量对最小残留疾病 (MRD) 的评估.
- 对复发性/耐药性ALL的新型FDA批准的治疗方法的评估.
主要成果:
- 由于化疗和新型药物,ALL结局的显著改善.
- 抗治疗病例的出现需要新的治疗策略.
- 关键的预测因素包括疾病负担,遗传异常和MRD.
结论:
- 新型治疗方法如TKIs,blinatumomab,inotuzumab,ozogamicin,rituximab和CAR T细胞疗法在复发性/耐药性ALL中显示出有效性.
- 预测模型可以预测不良事件.
- 精准医学,利用有效的预测平台,是个性化的ALL治疗的未来.
关键词:
急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.布莱纳图莫马巴姆是什么意思在CAR-T细胞疗法中.伊诺图祖马布 (inotuzumab) 是一种奥佐加米辛的药物.精准医学是一门精准的医学.预测和预后因素.这里是TKI TKI.更多相关视频
10:46Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos
Published on: May 23, 2025
222
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497